Suchergebnisse - "McGann, Mary"

PubPharm (37)

1

How to manage prolonged immune effector cell-associated hematotoxicity (ICAHT) related to BCMA-directed myeloma therapy

enthalten in: Expert review of anticancer therapy | 2024

von Davis, J. | McGann, M. | Marini, J. | +1

2

A comparative review of Aphexda and Mozobil for mobilization prior to stem cell collection

enthalten in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners | 2024

von Dietz, L. | Marini, J. | Hashmi, H. | +1

3

Safety and efficacy of eltrombopag in patients with post-CAR T cytopenias

enthalten in: European journal of haematology | 2024

von Wesson, W. | Ahmed, N. | Rashid, A. | +10

4

Early versus standard management of chimeric antigen receptor therapy toxicities and management's impact on safety and efficacy

enthalten in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners | 2024

von Gaffney, K. | Davis, J. | McGann, M. | +6

5

Safety and efficacy of eltrombopag in patients with post‐ CAR T cytopenias

enthalten in: European Journal of Haematology | 2024

von Wesson, W. | Ahmed, N. | Rashid, A. | +10

6

Early cytopenias and infections following chimeric antigen receptor T-Cell therapy for hematologic malignancies

enthalten in: Leukemia & lymphoma | 2023

von McGann, M. | Velayati, A. | Roubal, K. | +5

CommentOn: Leuk Lymphoma. 2022 Aug;63(8):1849-1860. - PMID 35389319

7

Role of tixagevimab-cilgavimab in preventing SARS-CoV-2 in hematopoietic stem cell transplant and chimeric antigen receptor T-cell therapy recipients

enthalten in: Journal of medical virology | 2023

von Thurlapati, A. | McGann, M. | Davis, J. | +9

8

Stem Cell Mobilization for Multiple Myeloma Patients Receiving Daratumumab-Based Induction Therapy : A Real- World Experience

enthalten in: Transplantation and cellular therapy | 2023

von Thurlapati, A. | Roubal, K. | Davis, J. | +8

9

The incidence and characteristics of VTE within 100 days of CAR T-cell therapy

enthalten in: Annals of hematology | 2023

von Gaffney, K. | McGann, M. | Davis, J. | +2

10

Use of long-term corticosteroids in patients treated with CAR T-cell therapy

enthalten in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners | 2023

von Hashmi, H. | McGann, M. | Greenwell, B.